Fecal calprotectin in patients with intestinal parasite infections
Part of Digestive system, Infections clinical trials.
This study looks at a protein in stool called calprotectin, which can show inflammation in the gut. It compares levels in people infected with certain parasites, those with gut symptoms but no parasites, and healthy volunteers to see if it helps identify infection-related inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must provide a stool sample for testing
- Must not have taken any antiparasitic drugs or antibiotics in the 2 weeks before the sample
- If you have gut symptoms, you can only be infected with Blastocystis or Entamoeba histolytica (not other parasites)
- If you have gut symptoms and no parasites, you can still participate
- Healthy volunteers without gut symptoms or any parasites are also needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the typical features and risk factors in children diagnosed with inflammatory bowel disease (IBD). It may help families understand what affects IBD in kids, even if it is not testing a new treatment.
This study is looking at a protein called calprotectin in the stool of babies and young children with Hirschsprung's disease. The goal is to see if it can help detect a serious gut inflammation called enterocolitis earlier.
This trial tests a new stool test to measure calprotectin levels, which could help doctors tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). If you have symptoms like stomach pain, diarrhea, or weight loss and are about to have a colonoscopy, you may be able to join.
This trial tests whether a blood test called calprotectin can help doctors spot infections in surgical patients with belly problems. It may help doctors decide if you need antibiotics or other treatments.
This study looks at stool samples to see if certain markers can quickly tell whether a biologic medicine is starting to work for moderate-to-severe ulcerative colitis. If successful, this could help doctors make faster, smarter treatment decisions.
This study tests non-invasive tools to find active inflammation in people with Crohn's disease or ulcerative colitis. You may need to give extra stool samples before your colonoscopy and calprotectin test.
Hear when a new Fecal Calprotectin in Intestinal Protozoa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.